Kate

Parkinson’s is not a $50 billion problem, it is an $82 billion crisis. Economic burden means the total cost of a disease including medical care, lost work, caregiving and everyday life expenses. A new report led by the The Michael J. Fox Foundation in partnership w/ APDA and Parkinson's Foundation shows just how dramatically we have underestimated the true cost of Parkinson’s and related disorders in the United States. Key Points: - The total economic burden of Parkinson’s disease and atypical parkinsonism in 2024 is estimated at over $82 billion annually, far exceeding prior estimates near $50 billion. - Costs extended far beyond medical care and included indirect costs like lost income and productivity as well as non-medical costs such as home modifications, transportation and caregiving. - Care partners contribute substantially to the economic burden, with billions of dollars in lost wages and productivity tied to caregiving responsibilities. My take: This is a wakeup call. Parkinson’s is not just a neurological condition, it is an economic and societal challenge affecting families, communities and health systems. We have been undercounting the true impact for years. When we include care partners, lost productivity and real world expenses, the numbers tell a much bigger story. Here are 5 points that resonated w/ me: 1- Parkinson’s is a whole family disease and the costs extend far beyond the individual living w/ the diagnosis. 2- Non-medical costs such as transportation, housing and daily support are major drivers and have been underestimated. 3- Care partners are carrying a hidden economic burden that must be recognized and supported. 4- Government programs shoulder a large portion of the cost, highlighting the need for policy level solutions. 5- If we do not act on prevention, access and better treatments, these costs will continue to rise rapidly over the next decades. michaeljfox.org/publication/… @MichaelJFoxOrg @APDAParkinsons @ParkinsonDotOrg